Maybe someday, someone will tell the story of how a plate of chocolate chip cookies created the San Diego biotech industry. And changed the world.
How in the 1960's, the wife of a San Diego state senator took chocolate chip cookies to the Sacramento king pins who thought the idea of a world class scientific university in San Diego was crazy.
But after eating the cookies, that it was great.
And how today, the University of California San Diego is square in the middle of revolution in biotechnology that includes Isis Pharmaceuticals. Isis is just one of dozens of San Diego companies all located within a glider ride of the University. All racing to make medicines better, faster, less expensive.
People who listen to the Best Stocks Now radio show every day are no stranger to Isis. I have also written about it several times.
Let's look at what they do, and how well they do it. For patients. And shareholders. And why today, this is one of our higher rated stocks on our Buy list.
Isis Pharmaceuticals – Making Sense of Antisense
Isis Pharmaceuticals (ISIS), based in Carlsbad, California, is a leader in something called “antisense technology.” It is an important breakthrough in the way we treat disease. The company has developed a drug discovery platform based on RNA-targeted technologies as opposed to traditional protein targets. RNA is an optimal drug target for the following reasons:
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.